SC ruling unleashes ₹500Cr AI healthcare hub with 6,000 tech jobs

For the AI industry, the removal of legal barriers around the Ameenpur campus signals a major investment in large-scale AI infrastructure tailored to healthcare. The project will require a deep bench of machine learning engineers, NLP specialists, and bioinformaticians, while planned collaborations with academic and startup partners could accelerate the deployment of AI models in clinical settings—a real-world testbed for India's national AI ambitions.

Hyderabad-based Pulsus Group has announced a ₹500 crore (approximately $60 million) investment to accelerate the expansion of its Ameenpur AI Healthcare and Digital Innovation Hub, targeting 6,000 direct jobs and an estimated 30,000 indirect positions. The investment unlocks a 35-acre campus near Miyapur in Telangana, following a recent Supreme Court ruling that upheld the project's IT/ITeS Park and Special Economic Zone (SEZ) status. This legal clarity removes years of regulatory uncertainty and enables Pulsus to fast-track development of a facility poised to become a major hub for artificial intelligence, healthcare technology, and digital services.

“

Pulsus Group, a medical technology and scientific publishing company, has a track record that underscores the feasibility of its ambitious targets.

The Supreme Court's intervention is critical. The Ameenpur project was conceived as a technology and employment generator but faced delays due to legal and regulatory challenges. With the SEZ status confirmed, Pulsus can now move forward with fresh capital investment, leveraging the zone's incentives—tax benefits, streamlined customs, and operational flexibility—to attract global healthcare information and research support markets. The ruling not only validates the project but also de-risks future expansions for similar public-private technology parks in India, potentially influencing investor confidence in the broader SEZ framework.

Pulsus Group, a medical technology and scientific publishing company, has a track record that underscores the feasibility of its ambitious targets. Parliamentary records cited by the company show that its subsidiary Omics International generated 2,836 direct jobs by March 2022 under the India BPO Promotion Scheme, while its Visakhapatnam operations aimed for around 6,000 jobs with 30,000 indirect livelihoods. At Ameenpur, the company reports having already created around 1,500 direct jobs, indicating that the hub is past the pilot phase and now entering a scale-up mode. The ₹500 crore infusion is expected to create demand for software engineers, AI and machine learning specialists, healthcare data scientists, bioinformatics experts, clinical research associates, and digital service professionals, strengthening Telangana's growing technology and life sciences ecosystem, particularly along the Miyapur growth corridor.

From a market perspective, the investment aligns with India's National Strategy for Artificial Intelligence and its push to become a global digital health destination. Telangana has been cultivating an IT and life sciences hub in Hyderabad, and the Ameenpur campus adds a dedicated AI healthcare vertical. The focus on AI-driven health solutions, clinical research, bioinformatics, and data analytics positions the hub to serve both domestic and international markets. By integrating academic partnerships with universities, research institutions, startups, and technology firms, Pulsus aims to create a collaborative innovation ecosystem rather than a standalone facility, potentially accelerating the translation of AI research into clinical practice.